CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's...
San Antonio, Texas, United States and 67 other locations
and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndr...
Phase 1, Phase 2
San Antonio, Texas, United States and 16 other locations
progression of AD, as compared to no stimulation (OFF), by measuring baseline (pre-implantation) to 12-month change in the integrated Alzheimer's...
San Antonio, Texas, United States and 20 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
San Antonio, Texas, United States and 111 other locations
Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...
Phase 2
San Antonio, Texas, United States of America and 36 other locations
be from 2 clinical subgroups: mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild Alzheimer's disease...
Phase 2
San Antonio, Texas, United States and 168 other locations
This is a phase 2A multi-center, randomized, double blind, placebo-controlled, parallel group study of varoglutamstat, with a stage gate to phase 2B....
Phase 2
San Antonio, Texas, United States and 21 other locations
This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...
San Antonio, Texas, United States and 52 other locations
randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's...
Phase 3
San Antonio, Texas, United States and 52 other locations
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Phase 2
San Antonio, Texas, United States and 133 other locations
Clinical trials
Research sites
Resources
Legal